Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-31

Clinical Trial Update: Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating bloodstream absorption of Avastin and Lucentis after intravitreal injection in diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)
  • Lucentis (ranibizumab)

Snippet

Sponsor: Queen's University | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2019-05-31